Fitch: Excess and Surplus Insurance Lines Will Outperform P/C Industry

CHICAGO--(BUSINESS WIRE)-- Excess and surplus (E&S) underwriters will likely outperform standard market underwriters in 2017 even if underwriting profitability weakens in 2017, according to Fitch Ratings' latest U.S. Excess and Surplus Lines Market Review report.

E&S underwriters outperformed the property/casualty (P/C) industry's combined ratio by an average of 8 percentage points from 2011-2015. E&S market direct premiums written (DPW) grew 4% in 2015, representing the fifth consecutive year of positive growth. However, initial data for first-half 2016 shows a slight decline in DPW from the prior year.

"As E&S insurer premium rates began to flatten in 2015, Fitch does not expect positive rate movement due to competitive market conditions and recent industry consolidation, and profitability will likely deteriorate modestly in 2017," said Gerald Glombicki, Director, Fitch Ratings.

The E&S market provides an alternative for hard to place nonhomogeneous risks that require substantive underwriting expertise. Fitch believes that successful companies in this environment are traditionally strong underwriters, have solid niche market positions, and have geographically diverse product offerings with which to take advantage of attractive rates in select areas of the market.

"The E&S market is increasingly becoming an attractive alternative for reinsurers with E&S underwriting capabilities to offset reduced reinsurance premiums," added Glombicki.

Underwriting outperformance in the E&S market is concentrated in the commercial multi-peril and medical professional liability lines, both exhibiting a strong advantage over the P/C industry. The E&S market did not underperform the P/C industry in any line over the past five years; however, performance varies from year to year and by company.

Although the E&S market is highly specialized, it remains dominated by large, standard market insurers and the top two, Lloyds of London and American International Group, Inc., account for almost 35% of total premiums. While Fitch does not expect many new entrants into the market, we note that Berkshire is rapidly expanding, with direct written premiums growing nearly 50% two years in a row.

Insurers with the most favorable and least volatile underwriting results for the 2011-2015 period include Alleghany Group; QBE North America; and Travelers Companies, Inc. Insurers with the worst and most volatile results are American International Group, Inc.; Fairfax Financial Holdings, Ltd.; and State National Insurance Company, Inc.

The "US Excess and Surplus Lines Market Review" report is available at www.fitchratings.com or by clicking on the link.

Link to Fitch Ratings' Report: U.S. Excess and Surplus Lines Market Review (Strong Market Performance Continues)

https://www.fitchratings.com/site/re/887263

Additional information is available at www.fitchratings.com

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTPS://WWW.FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEB SITE AT WWW.FITCHRATINGS.COM. PUBLISHED RATINGS, CRITERIA, AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE, AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE CODE OF CONDUCT SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

Copyright (c) 2016 by Fitch Ratings, Inc., Fitch Ratings Ltd. and its subsidiaries. 33 Whitehall Street, NY, NY 10004. Telephone: 1-800-753-4824, (212) 908-0500. Fax: (212) 480-4435. Reproduction or retransmission in whole or in part is prohibited except by permission. All rights reserved. In issuing and maintaining its ratings and in making other reports (including forecast information), Fitch relies on factual information it receives from issuers and underwriters and from other sources Fitch believes to be credible. Fitch conducts a reasonable investigation of the factual information relied upon by it in accordance with its ratings methodology, and obtains reasonable verification of that information from independent sources, to the extent such sources are available for a given security or in a given jurisdiction. The manner of Fitch's factual investigation and the scope of the third-party verification it obtains will vary depending on the nature of the rated security and its issuer, the requirements and practices in the jurisdiction in which the rated security is offered and sold and/or the issuer is located, the availability and nature of relevant public information, access to the management of the issuer and its advisers, the availability of pre-existing third-party verifications such as audit reports, agreed-upon procedures letters, appraisals, actuarial reports, engineering reports, legal opinions and other reports provided by third parties, the availability of independent and competent third- party verification sources with respect to the particular security or in the particular jurisdiction of the issuer, and a variety of other factors. Users of Fitch's ratings and reports should understand that neither an enhanced factual investigation nor any third-party verification can ensure that all of the information Fitch relies on in connection with a rating or a report will be accurate and complete. Ultimately, the issuer and its advisers are responsible for the accuracy of the information they provide to Fitch and to the market in offering documents and other reports. In issuing its ratings and its reports, Fitch must rely on the work of experts, including independent auditors with respect to financial statements and attorneys with respect to legal and tax matters. Further, ratings and forecasts of financial and other information are inherently forward-looking and embody assumptions and predictions about future events that by their nature cannot be verified as facts. As a result, despite any verification of current facts, ratings and forecasts can be affected by future events or conditions that were not anticipated at the time a rating or forecast was issued or affirmed.

The information in this report is provided "as is" without any representation or warranty of any kind, and Fitch does not represent or warrant that the report or any of its contents will meet any of the requirements of a recipient of the report. A Fitch rating is an opinion as to the creditworthiness of a security. This opinion and reports made by Fitch are based on established criteria and methodologies that Fitch is continuously evaluating and updating. Therefore, ratings and reports are the collective work product of Fitch and no individual, or group of individuals, is solely responsible for a rating or a report. The rating does not address the risk of loss due to risks other than credit risk, unless such risk is specifically mentioned. Fitch is not engaged in the offer or sale of any security. All Fitch reports have shared authorship. Individuals identified in a Fitch report were involved in, but are not solely responsible for, the opinions stated therein. The individuals are named for contact purposes only. A report providing a Fitch rating is neither a prospectus nor a substitute for the information assembled, verified and presented to investors by the issuer and its agents in connection with the sale of the securities. Ratings may be changed or withdrawn at any time for any reason in the sole discretion of Fitch. Fitch does not provide investment advice of any sort. Ratings are not a recommendation to buy, sell, or hold any security. Ratings do not comment on the adequacy of market price, the suitability of any security for a particular investor, or the tax-exempt nature or taxability of payments made in respect to any security. Fitch receives fees from issuers, insurers, guarantors, other obligors, and underwriters for rating securities. Such fees generally vary from US$1,000 to US$750,000 (or the applicable currency equivalent) per issue. In certain cases, Fitch will rate all or a number of issues issued by a particular issuer, or insured or guaranteed by a particular insurer or guarantor, for a single annual fee. Such fees are expected to vary from US$10,000 to US$1,500,000 (or the applicable currency equivalent). The assignment, publication, or dissemination of a rating by Fitch shall not constitute a consent by Fitch to use its name as an expert in connection with any registration statement filed under the United States securities laws, the Financial Services and Markets Act of 2000 of the United Kingdom, or the securities laws of any particular jurisdiction. Due to the relative efficiency of electronic publishing and distribution, Fitch research may be available to electronic subscribers up to three days earlier than to print subscribers.

For Australia, New Zealand, Taiwan and South Korea only: Fitch Australia Pty Ltd holds an Australian financial services license (AFS license no. 337123) which authorizes it to provide credit ratings to wholesale clients only. Credit ratings information published by Fitch is not intended to be used by persons who are retail clients within the meaning of the Corporations Act 2001.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160926006195/en/

Fitch Ratings
Gerald Glombicki
Director
Fitch Ratings, Inc.
70 West Madison St
+1-312-606-2354
or
James Auden
Managing Director
+1-312-368-3146
or
Media Relations
Hannah James, + 1 646-582-4947
[email protected]

Source: Fitch Ratings

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Engineered Tax Services Names Sarah Herndon CFO
• Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia
• BN Strategic Metals Corporation Advances Black Hawk and Atolia Tungsten Projects Amid Strong Tungsten Market Fundamentals